Facebook
Twitter
LinkedIn
Forward
8th Annual Updates from ASH 2022: Practice Changing Abstracts
Chicago, IL US
February 24, 2023
This activity's goal is to join community-based providers and academic oncologists to improve the care and outcomes of patients with hematologic malignancies. To reach this goal, this activity will address early treatment options and medical advances that can be implemented to reduce cancer-related deaths, including CAR T-cell therapy and novel therapeutics for the state-of-the-art management of newly-diagnosed and relapsed blood cancers. It will keep all healthcare professionals who care for patients with hematologic malignancies abreast of the latest scientific updates, innovative ideas, and the timeliest issues related to their care.
It will also provide participants with information to improve patient management and care strategies. They will discuss rapidly evolving developments, discover new treatments for patients, and improve practice paradigms. This activity will educate them on best practices for treating hematologic cancers and inform them of the indications to refer patients for expert quaternary-level care for advanced cellular therapies.
Learn more at the conference website!
It will also provide participants with information to improve patient management and care strategies. They will discuss rapidly evolving developments, discover new treatments for patients, and improve practice paradigms. This activity will educate them on best practices for treating hematologic cancers and inform them of the indications to refer patients for expert quaternary-level care for advanced cellular therapies.
Learn more at the conference website!
Target Audience
This activity is designed for primary care physicians, hematologists, pathologists, medical oncologists, trainees, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals dedicated to treating hematologic cancers.
Learning Objectives
After this activity, participants will be able to:
- Illustrate how cutting-edge data presented at the 2022 Annual Meeting of the American Society of Hematology can apply to clinical practice;
- State the emerging treatment strategies for patients with low-risk and high-risk myeloid malignancies;
- Discuss the optimal patient selection, timing, and regimen for transplant;
- Evaluate clinical trial data in the context of CAR T-cell therapy and its place in evolving hematologic malignancy treatment standards;
- Choose the optimal treatment, sequencing, and supportive care strategies for patients with lymphoma using evidence-based guidelines;
- Identify methods for integrating therapeutic advances into practice to improve current myeloma patient care;
- Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common benign hematologic diseases and COVID-associated hematologic diseases.
The agenda is subject to change.
Convene
333 N Green Street
Chicago, IL
60607
United States
HYBRID CONFERENCE
Attendees can participate in person or virtually. For more information, contact Meeting Achievements via e-mail.
WANT TO KNOW MORE?
Learn more about the conference by visiting the conference website!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Meeting Achievements via e-mail via at support@meetingachievements.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO COURSE DIRECTOR
Michael R. Bishop, MDProfessor of Medicine
Director, Jonas Center for Cellular Therapy
Director, Hematopoietic Stem Cell Transplantation Program
UNIVERSITY OF CHICAGO PLANNING COMMITTEE
Luca Capicchinoi, MSL Assistant Director, Cancer Services Administrator, Jonas Center for Cellular Therapy | Mylove Mortel, MSPH, RN, OCN Assistant Director, Transplant & Cell Therapy Clinical Operations |
Jennifer Cooperrider, MD Fellow, Hematology/Oncology | Toyosi Odenike, MD Professor of Medicine Director, Leukemia Program |
Andrzej Jakubowiak, MD, PhD Professor of Medicine Director, Myeloma Program | Sonali Smith, MD Elwood V. Jensen Professor in Medicine Chief, Sections of Hematology/Oncology |
Justin Kline, MD Associate Professor of Medicine Director, Lymphoma Program |
GUEST FACULTY
Laurie Sehn, MD
Clinical Assistant Professor
University of British Columbia
Clinical Assistant Professor
University of British Columbia
UNIVERSITY OF CHICAGO FACULTY
Kenneth Cohen, MD Assistant Professor of Medicine | Hongtao Liu, MD, PhD Associate Professor of Medicine |
| Benjamin A. Derman, MD Assistant Professor of Medicine | Mariam Nawas, MD Assistant Professor of Medicine |
Satyajit Kosuri, MD Assistant Professor of Medicine | Anand Patel, MD Assistant Professor of Medicine |
| Adam DuVall, MD, MPH Assistant Professor of Medicine | Peter A. Riedell, MD Assistant Professor of Medicine |
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 7.25 contact hours.
American Board of Internal Medicine MOC II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Pediatrics MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Pediatrics's (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Pediatrics's (ABP) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
EXHIBIT OPPORTUNITIES ARE AVAILABLE! SPACE IS LIMITED, SO SIGN UP TODAY!
This conference offers a tremendous opportunity to highlight your company's products, services, and achievements in front of a wide array of key decision-makers. Increase your company profile by participating as an exhibitor at this exciting event.
We are pleased to provide opportunities for organizations to advertise their products and services to conference attendees. Whether you are sharing information about your company's products, connecting with physicians during one of the scheduled breaks, or gaining brand recognition for your company through program acknowledgments, your message will reach physicians, hematologists, pathologists, medical oncologists, trainees, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals dedicated to the treatment of hematologic cancers.
Download the prospectus 
here or contact Meeting Achievements at support@meetingachievements.com or (219) 465-1115. We hope to see you there!
here or contact Meeting Achievements at support@meetingachievements.com or (219) 465-1115. We hope to see you there!
REGISTRATION
Early rates expire on December 21, so reserve your spot today!
Profession Type | In Person | Virtual |
|---|---|---|
Physicians | $75/$100 | $30/$40 |
Nurses, Pharmacists, Other Healthcare Professionals | $35/$50 | $25/$30 |
Residents & Fellows with a verification letter | $25 | $25 |
| Industry | $395 | $195 |
CANCELLATION POLICY Please see the registration site for the full details. | ||
JOINING THE VIRTUAL CONFERENCE
You will receive login information from Meeting Achievements via the e-mail address used at registration 48 hours before the conference. Onsite/Day of registrants, please allow 10-15 minutes post-registration for access information to be generated.
If you need assistance joining the session or experience other technical issues, contact technical support.
If you need assistance joining the session or experience other technical issues, contact technical support.
CLAIMING CREDIT
After creating an account or logging in, enter the access code to unlock the credit claiming process.
Please Note: The credit claiming process will close three months after the conference ends. Requests to claim credit after three months will be subject to additional fees.
Please login or create an account to proceed.